Clinical Trial Update: A Study of TIL in Advanced Solid Tumors (DFGD) [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating tumor-infiltrating lymphocytes (TIL) therapy in patients with advanced solid tumors. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Tumor-infiltrating lymphocytes (TIL) therapy

Snippet

Sponsor: Shanghai Juncell Therapeutics | Conditions: Advanced Solid Tumor, Tumor Infiltrating Lymphocytes | EARLY_Phase 1 | Status: RECRUITING